The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Epiretinal brachytherapy for wet age related macular degeneration.

  • Description

    Macular degeneration affects the area of the back of the eye that responsible for central vision (the macula). There are two types – ‘dry’ and ‘wet’. The wet form is caused by bleeding from the formation of new blood vessels. Loss of vision is progressive and often rapid.

    Radiotherapy has been used in people with wet age-related macular degeneration to treat the  new blood vessels growing under the macula. A probe is carefully inserted into the eye through a small incision and radiation therapy used to destroy the new blood vessels. The aim of this procedure is toslow down sight loss or stabilise the patient’s vision.

  • OPCS4.6 Code(s)

    X65.8 Other specified radiotherapy delivery

    Y35.4 Introduction of radioactive substance into organ for brachytherapy NOC

    Y89.- Brachytherapy (where necessary)

    Z19.3 Retina

    In addition the ICD-10 code H35.3 Degeneration of macula and posterior pole would be recorded.


    The NHS Classifications Service of the Health and Social Care Information Centre is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS.  The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided.


  • Get involved